- •Chapter 1
- •Ocular Adnexal Lymphoproliferative
- •1.1 Pathogenesis
- •1.2 Chronic Antigen Stimulation
- •1.3 Immunosuppression
- •1.4 Pathology
- •1.5 Cytogenetics
- •1.6 Clinical Features
- •1.7 Imaging Findings
- •1.8 Staging
- •1.9 Positron Emission Tomography
- •1.10 Treatment
- •1.11 Follicular Lymphoma
- •1.12 Mantle Cell Lymphoma
- •1.13 Radiotherapy
- •1.14 Chemotherapy
- •1.15 Immunotherapy
- •1.16 Radioimmunotherapy
- •1.17 Outcome
- •1.18 The Future
- •References
- •Chapter 2
- •2.1 General Introduction
- •2.2 The Aging Process and Facial Analysis
- •2.3 Endoscopic Brow Lift
- •2.3.1 Introduction
- •2.3.2 Endoscopic Browlift Anesthesia Pearls
- •2.3.4 Endoscopic Browlift Postoperative Care Pearls
- •2.4 Upper Blepharoplasty
- •2.4.1 Introduction
- •2.4.2 Patient Evaluation
- •2.4.3 Upper Blepharoplasty Anesthesia Pearls
- •2.4.4 Upper Blepharoplasty Surgical Procedure Pearls
- •2.5 Lower Blepharoplasty, Fillers, and Midface Augmentation
- •2.5.1 Introduction
- •2.5.2 Patient Evaluation
- •2.5.3 Lower Blepharoplasty Anesthesia Pearls
- •2.5.4 Lower Blepharoplasty Surgical Procedure Pearls
- •References
- •Chapter 3
- •3.1 Introduction
- •3.2 What Is the Diagnosis?
- •3.2.1 Pitfalls of Diagnosis
- •3.2.2 A Diagnostic Corticosteroid Trial?
- •3.2.3 The Question of Biopsy
- •3.3 Treatment
- •3.3.1 Corticosteroids
- •3.3.2 Radiation
- •3.3.3 Other Agents
- •3.4 Special Circumstances
- •3.4.1 Pediatric IOIS
- •3.4.2 Sclerosing Pseudotumor
- •3.4.3 Tolosa–Hunt Syndrome
- •References
- •Chapter 4
- •4.1 Introduction
- •4.2 Embryology, Anatomy, Physiology, and Pathophysiology of the Canalicular System
- •4.3 Infective Causes
- •4.3.1 Periocular Herpes Simplex Infection
- •4.3.2 Bacterial Canaliculitis
- •4.4.1 Lichen Planus
- •4.4.2 Ocular Cicatricial Pemphigoid
- •4.5 Iatrogenic Causes
- •4.5.1 Systemic Drugs
- •4.5.1.2 Docetaxel (Taxotere)
- •4.5.2 Radiotherapy
- •4.5.3 Topical Ophthalmic Treatments
- •4.5.3.2 Mitomycin C (MMC) Therapy
- •4.5.4 Lacrimal Stents and Plugs
- •4.6 The Surgical Approach to Managing Canalicular Disease
- •4.6.1 Surgical Technique for Dacryocystorhinostomy with Retrograde Canaliculostomy
- •References
- •Chapter 5
- •5.1 Introduction
- •5.2 Nomenclature
- •5.3 Clinical Manifestations of NF1
- •5.4 Orbitofacial Tumors in NF1
- •5.4.2 Malignant Peripheral Nerve Sheath Tumors
- •5.4.3 Optic Pathway Gliomas
- •5.5 Genetics
- •5.5.1 The NF1 Gene
- •5.5.2 Overlapping NF1-Like Phenotype (SPRED1)
- •5.6.1 Introduction
- •5.7 Surgical Management of Orbitofacial Tumors in NF1
- •5.7.1 Introduction
- •5.7.2 Timing of Surgery
- •5.7.3 Periorbital Involvement
- •5.7.3.1 The Upper Eyelid
- •5.7.3.2 The Lower Eyelid and Midface
- •5.7.4 Orbital Involvement
- •5.7.4.1 Proptosis
- •5.7.4.3 Proptosis Due to Optic Nerve Glioma
- •5.7.4.4 Orbital Enlargement with Dystopia and Hypoglobus
- •5.8 The Natural History of NF1 Tumor Growth from Birth to Senescence
- •References
- •Chapter 6
- •6.1 Introduction
- •6.2 Surgical Anatomy of the Lacrimal Drainage System
- •6.3 Basic Diagnostics for Disorders of the Lacrimal Drainage System
- •6.4 Selective Lacrimal Sac Biopsy in External Dacryocystorhinostomy
- •6.5.1 Case A
- •6.5.2 Case B
- •6.5.3 Case C
- •6.5.4 Case D
- •6.5.5 Case E
- •6.5.6 Case F
- •6.5.7 Case G
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Patients
- •7.2.2 Examination
- •7.3 Results
- •7.3.1 Patient Data
- •7.3.3 Family History
- •7.3.4 Pregnancy History
- •7.3.5 Birth
- •7.3.6 Associated Systemic and Ocular Diseases
- •7.3.8 Neuroradiological Findings (Brain MRI)
- •7.3.9 Nasolacrimal System Findings
- •7.4 Discussion
- •7.4.1 Patients
- •7.4.2 Obstetric and Family History
- •7.4.3 Associated Pathologies
- •7.4.3.1 Ophthalmological Findings in Unilateral Disease
- •7.4.3.2 Neuroradiological Findings
- •7.4.3.3 Systemic Diseases
- •7.4.3.4 Nasolacrimal Duct Findings
- •7.5 Conclusions
- •References
- •Chapter 8
- •8.1 Introduction
- •8.2 Evaluation of Complicated Ptosis
- •8.2.1 Compensatory Eyebrow Elevation
- •8.2.3 Innervation Patterns of the Frontalis Muscle
- •8.2.4 Checklist of Preoperative Evaluation of Complicated Ptosis
- •8.3 Surgical Technique of Levator Muscle Recession
- •8.3.1 Principle
- •8.3.2 Approach to the Levator
- •8.3.3 Partial Levator Recession
- •8.3.4 Total Levator Recession
- •8.3.6 Undercorrection and Overcorrection
- •8.4 Surgical Technique of Brow Suspension
- •8.4.1 Materials for Brow Suspension
- •8.4.1.1 Nonautogenous Materials
- •8.4.1.2 Autogenous Fascia Lata
- •8.4.2 Our Technique of Harvesting Autogenous Fascia Lata
- •8.4.3 Mechanical Principals of Brow Suspension
- •8.4.4 Upper Lid Approach
- •8.4.5 Fascia Implantation
- •References
- •Chapter 9
- •Modern Concepts in Orbital Imaging
- •9.1 Computerized Tomography
- •9.2 Three-Dimensional Imaging
- •9.3 Magnetic Resonance Imaging
- •9.3.1 The T1 Constant
- •9.3.2 The T2 Constant
- •9.3.3 Creating the MR Image
- •9.4 Imaging of Common Orbital Lesions
- •9.4.1 Adenoid Cystic Carcinoma
- •9.4.2 Cavernous Hemangioma
- •9.4.3 Dermoid Cyst
- •9.4.4 Fibrous Dysplasia
- •9.4.5 Lymphangioma
- •9.4.6 Lymphoma
- •9.4.7 Myositis
- •9.4.8 Optic Nerve Glioma
- •9.4.9 Pseudotumor
- •9.4.10 Rhabdomyosarcoma
- •9.6 Positron Emission Tomography
- •9.7 Orbital Ultrasound
- •9.7.1 Physics and Instrumentation
- •9.7.1.1 Topographic Echography
- •9.7.1.2 Quantitative Echography
- •9.7.1.3 Kinetic Echography
- •9.7.2 Extraocular Muscles
- •9.7.3 Optic Nerves
- •References
- •Chapter 10
- •10.1 Introduction
- •10.3 Etiology
- •10.4 Microbiology
- •10.5 Changing Pathogens and Resistance
- •10.5.2 Orbital MRSA
- •10.6 Evaluation of Orbital Cellulitis
- •10.7 Medical Treatment of Orbital Cellulitis
- •10.8 Surgical Treatment of Orbital Cellulitis
- •10.9 Prevention of Orbital Cellulitis After Orbital Fracture
- •References
- •Chapter 11
- •11.1 Clinical Picture
- •11.1.1 Clinical Phases
- •11.2 Ocular Complications
- •11.3 Investigation
- •11.3.1 Angiography
- •11.4 Management
- •11.4.1 Active Nonintervention
- •11.4.2 Indications for Treatment
- •11.5 Modalities of Treatment
- •11.5.1 Steroids
- •11.5.1.1 Topical Steroids
- •11.5.1.2 Intralesional Corticosteroid Injection
- •11.5.1.3 Oral Corticosteroids
- •11.5.2 Interferon-Alfa
- •11.5.3 Vincristine
- •11.5.4 Laser
- •11.5.5 Embolization
- •11.5.6 Surgery
- •References
- •Chapter 12
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3 Biological Behavior and Timing of Metastasis
- •12.4 Lateralization
- •12.5 Localization
- •12.6 Clinical Features
- •12.7 Imaging and Patterns of Orbital Metastatic Disease
- •12.8 Biopsy
- •12.9 Common Types of Orbital Metastases
- •12.9.1 Breast Carcinoma
- •12.9.2 Lung Carcinoma
- •12.9.3 Prostatic Cancer
- •12.9.4 Melanoma
- •12.9.5 Carcinoid Tumor
- •12.11 Treatment
- •12.11.1 Radiotherapy
- •12.11.2 Chemotherapy
- •12.11.3 Hormonal Therapy
- •12.11.4 Surgery
- •12.12 Prognosis and Survival
- •References
- •Chapter 13
- •13.1 Introduction
- •13.2 Rituximab
- •13.3 Yttrium-90-Labeled Ibritumomab Tiuxetan
- •13.4 Imatinib Mesylate
- •13.5 Cetuximab
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Porous Orbital Implants
- •14.3 Orbital Implant Selection in Adults
- •14.4 Orbital Implant Selection in Children
- •14.5 Volume Considerations in Orbital Implant Selection
- •14.7 Which Wrap to Use
- •14.8 To Peg or Not to Peg Porous Implants
- •14.9 Summary
- •References
- •Chapter 15
- •15.1 Introduction
- •15.2 Etiology and Presentation
- •15.2.1 Etiology of Orbital Volume Loss
- •15.2.2 Etiology of Periorbital Volume Loss
- •15.2.3 Features of Orbital Volume Loss
- •15.2.4 Features of Periorbital Volume Loss
- •15.3 Background to Injectable Soft-Tissue Fillers
- •15.3.1 Historical Perspective on Volume Replacement
- •15.4 Types of Injectable Soft-Tissue Filler
- •15.4.1 Collagen Fillers
- •15.4.2 Hyaluronic acid Fillers
- •15.5 Treatment Areas
- •15.5.1 Orbit
- •15.5.2 Upper Eyelid and Brow
- •15.5.3 Tear Trough
- •15.5.4 Temple and Brow
- •15.6 Other Periorbital Uses of Injectable Soft-Tissue Fillers
- •15.6.1 Upper Eyelid Loading
- •15.6.2 Lower Eyelid Elevation
- •15.6.3 Treatment of Cicatricial Ectropion
- •15.7 Future Developments
- •References
|
|
106 |
7 Systemic and Ophthalmic Anomalies in Congenital Anophthalmic or Microphthalmic Patients |
||||||
|
|
|
|
|
|
|
|
||
|
|
7.2 |
Patients and Methods |
|
7.3 |
Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.2.1 |
|
Patients |
|
7.3.1 |
Patient Data |
|
|
7 |
|
|
|
|
|||||
|
A prospective study was conducted of all patients with |
To date, 75 patients (35 girls and 40 boys) have been |
|||||||
|
|
congenital clinical anophthalmos and blind microphthal- |
treated. |
|
|
|
|||
|
|
|
|
|
|||||
|
|
mos who were treated at least once with a hydrogel |
The patient sample was composed |
Patients |
Orbits |
||||
|
|
expander in the Ophthalmology Department of the |
|||||||
|
|
University of Rostock during the period after the first |
as follows |
|
|
||||
|
|
introduction of hydrogel expander therapy in September |
Unilateral congenital clinical |
38 |
38 |
||||
|
|
1997 until May 2008. No exclusion criteria were defined |
|||||||
|
|
anophthalmos |
|
|
|||||
|
|
for this study. |
|
|
|||||
|
|
Bilateral congenital clinical |
20 |
40 |
|||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
anophthalmos |
|
|
|
|
|
|
|
|
|
Unilateral blind microphthalmos |
16 |
16 |
|
|
|
|
|
|
|
Bilateral blind microphthalmos |
1 |
2 |
|
|
|
7.2.2 |
|
Examination |
|
||||
|
|
|
|
Total |
|
75 |
96 |
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
In addition to a routine ophthalmological examination, the following specific patient data were collected:
■Details were elicited concerning the course of pregnancy and delivery, and these were supplemented by discharge summaries from previously treating hospitals if available.
■When taking the family history, special emphasis was placed on gathering information about developmental anomalies.
■The results of pediatric examinations were included to rule out associated systemic changes (syndromes, organ anomalies, metabolic disorders, etc.).
■Magnetic resonance imaging (MRI) was generally performed to exclude developmental cerebral anomalies.
■For the assessment of the nasolacrimal ducts, routine probing and irrigation of the nasolacrimal system was performed under anesthesia prior to first-time surgery, as has been described in detail elsewhere [20].
The workup for genetic diagnosis is part of another ongoing study and is therefore not discussed here.
Summary for the Clinician
■Comprehensive evaluation of each case requires a thorough ophthalmological examination supplemented by assessment by an experienced pediatrician. MRI is generally necessary to detect for developmental cerebral anomalies.
Summary for the Clinician
■Distribution of the conditions was approximately equal between males and females. Unilateral anophthalmos was encountered almost twice as frequently as bilateral anophthalmos. Microphthalmos was the least common condition.
7.3.2Age
The age of the patients at initial presentation was between 1 and 90 months (median 4 months).
7.3.3Family History
|
Unilateral |
Bilateral |
|
(n = 54) |
(n = 21) |
Nothing of note, no |
39 |
14 |
siblings |
|
|
Nothing of note, |
12 |
7 |
siblings healthy |
|
|
Nothing of note, |
2 |
0 |
siblings unwell |
|
|
■ One child with postnatal middle cerebral artery
infarction
■One twin sister with iris coloboma
Positive, no siblings 1 |
0 |
■One cousin of father with bilateral anophthalmos
Summary for the Clinician
■With a single exception, the family histories were not positive for the conditions.
7.3.4 Pregnancy History
|
Unilateral |
Bilateral |
||
|
(n = 54) |
(n = 21) |
||
Nothing of |
48 |
|
16 |
|
note |
|
|
|
|
Noteworthy |
6 |
|
|
|
findings |
|
|
|
|
|
■ |
One in vitro |
■ |
One with |
|
|
fertilization, single |
|
acyclovir |
|
|
umbilical artery |
|
ingestion before |
|
■ |
One in vitro |
|
pregnancy, |
|
|
fertilization, |
|
single umbilical |
|
|
midcycle bleeding |
|
artery |
|
■ |
Two with hyperten- |
■ |
One with two |
|
|
sion requiring |
|
previous early |
|
|
treatment |
|
miscarriages |
|
■ |
One with consan- |
■ |
One mother |
|
|
guinous parents, |
|
with acromeg- |
|
|
four previous |
|
aly, history of |
|
|
miscarriages, |
|
pituitary |
|
|
mother with |
|
adenoma, |
|
|
Pena–Shokeir |
|
anterior |
|
|
syndrome (pseudo- |
|
pituitary lobe |
|
|
trisomy 18) |
|
insufficiency |
|
■ |
One with three |
■ |
One mother |
|
|
previous miscar- |
|
with a history |
|
|
riages, mother with |
|
of completed |
|
|
partial transposition |
|
treatment for |
|
|
of chromosome 13 |
|
syphilis |
|
|
to 15 |
■ |
One with |
|
|
|
|
nicotine abuse |
7.3 Results 107
Summary for the Clinician
■The course of pregnancy itself was routinely unexceptional.
7.3.5 Birth
|
Unilateral |
Bilateral |
|
(n = 54) |
(n = 21) |
Spontaneous |
35 |
19 |
Cesarean section |
19 |
2 |
(of which, before week 36) |
(4) |
0 |
Summary for the Clinician
■As expected, obstetric delivery was not a determinant of the clinical condition.
7.3.6Associated Systemic and Ocular Diseases
|
Unilateral |
Bilateral |
|
|
(n = 54) |
(n = 21) |
|
None/ocular |
24 |
|
11 |
findings only |
(13 Anophthalmos and |
(10 |
|
(Fig. 7.1) |
11 microphthalmos |
Anophthalmos |
|
|
patients) |
and 1 micro- |
|
|
|
|
phthalmos |
|
|
|
patients) |
None/but |
8 |
|
(No subdiffer- |
developmental |
Anophthalmos |
entiation |
|
anomaly of |
■ |
Two sclerocornea |
possible because |
fellow eye |
■ |
One coloboma of |
both |
(Fig. 7.2) |
|
iris, retina, choroid, |
eyes affected) |
|
|
and optic disc, with |
|
|
|
posterior pole |
|
|
|
involvement |
|
|
■ |
One iris coloboma, |
|
|
|
retina intact |
|
|
■ |
One nanophthal- |
|
|
|
mos with question- |
|
|
|
able light |
|
|
|
perception |
|
|
■ |
One aplasia of |
|
|
|
macula/optic disc |
|
108 |
7 Systemic and Ophthalmic Anomalies in Congenital Anophthalmic or Microphthalmic Patients |
Microphthalmos
|
|
■ |
One central stromal |
|
|
|
|
|
corneal scar |
|
|
7 |
|
|
|
|
|
|
■ |
One paracentral lens |
|
||
|
|
|
clouding, persistant |
|
|
|
|
|
|
||
|
|
|
hyperplastic |
|
|
|
|
|
primary vitreous |
|
|
|
|
|
(PHPV), aplasia of |
|
|
|
|
|
macula |
|
|
|
|
Unilateral |
Bilateral |
||
|
|
(n = 54) |
(n = 21) |
||
|
Associated |
14 |
|
10 |
|
|
disease; path- |
Anophthalmos |
■ |
One external |
|
|
ology of |
■ |
One clefting of |
|
auditory meatus |
|
fellow eye |
|
lip, upper jaw |
|
absent |
|
(Fig. 7.3) |
|
and palate, ear |
|
unilaterally, |
|
|
|
cartilage missing |
|
labyrinthine |
|
|
|
(no deafness), |
|
deafness, |
|
|
|
corpus callosum |
|
bilateral talipes |
|
|
|
hypoplasia; |
|
calcaneus |
|
|
|
coloboma of iris, |
■ |
One rudimen- |
|
|
|
retina, and chor- |
|
tary sixth finger |
|
|
|
oid in fellow eye |
|
on both hands |
|
|
■ |
One retardation, |
■ |
One |
|
|
|
labyrinthine |
|
plagiocephaly |
|
|
|
deafness on |
■ |
One septo-optic |
|
|
|
affected side; |
|
dysplasia, corpus |
|
|
|
sclerocornea, |
|
callosum aplasia |
|
|
|
secondary |
■ |
One Delleman |
|
|
|
glaucoma in |
|
syndrome |
|
|
|
fellow eye |
■ |
One microceph- |
|
|
■ |
One Goldenhar |
|
aly, statomotor |
|
|
|
syndrome; |
|
retardation, |
|
|
|
contralateral |
|
hearing loss |
|
|
|
clefting of lip, |
■ |
One micro- |
|
|
|
upper jaw, and |
|
cephaly, |
|
|
|
palate, cleft |
|
retardation |
|
|
|
tongue; auricular |
|
|
|
|
|
dysplasia; |
|
|
|
|
|
external auditory |
|
|
|
|
|
meatus absent; |
|
|
|
|
|
preauricular tags |
|
|
|
|
|
bilaterally; upper |
|
|
|
|
|
lid coloboma, |
|
|
|
|
|
lipodermoid of |
|
|
the limbus in fellow eye
■ |
One complex |
■ |
One agenesis of |
|
developmental |
|
corpus callosum, |
|
anomaly |
|
micrognathia, |
|
syndrome with |
|
respiratory |
|
hypertelorism, |
|
failure (died at |
|
bilateral clefting |
|
16 months) |
|
of lip, upper jaw |
■ |
One develop- |
|
and palate, |
|
mental delay, |
|
pre-auricular tag; |
|
labyrinthine |
|
Peters’ anomaly |
|
anomaly |
|
with secondary |
■ |
One myeliniza- |
|
glaucoma |
|
tion disorder |
|
requiring |
|
|
|
treatment in |
|
|
|
fellow eye |
|
|
■ |
One Goldenhar |
|
|
|
syndrome; |
|
|
|
limbus dermoid, |
|
|
|
severe Sjögren |
|
|
|
syndrome |
|
|
|
symptoms with |
|
|
|
corneal |
|
|
|
vascularization |
|
|
|
in fellow eye |
|
|
■ |
One craniofacial |
|
|
|
dysmorphism; |
|
|
|
sclerocornea in |
|
|
|
fellow eye |
|
|
■ |
One hexadactyly, |
|
|
|
epilepsy; |
|
|
|
nanophthalmos |
|
|
|
of fellow eye |
|
|
■ |
One familial |
|
|
|
facial syndrome |
|
|
|
and additional |
|
|
|
sixth toe; dense |
|
|
|
corneal clouding |
|
|
|
in fellow eye |
|
|
■ |
One cerebral |
|
|
|
retardation, |
|
|
|
deafness, |
|
|
|
septal agenesis; |
|
|
|
pitting of optic |
|
|
|
disc in fellow eye |
|
|
■ |
One massive |
|
|
|
growth |
|
|
|
retardation; iris |
|
|
|
coloboma in |
|
|
|
fellow eye |
|
|
■One central motor disturbance, focal epilepsy due to complex cerebral anomaly; coloboma of iris, retina, choroid, and optic disc in fellow eye
■One developmental anomaly of labyrinth; nystagmus in fellow eye
Microphthalmos
■One unilateral duplicate kidney; coloboma of iris, retina, and choroid in fellow eye, paracentral corneal turbidity
■One epilepsy, hemiparesis, unilateral hearing loss, developmental delay; PHPV, coloboma of iris, retina, and choroid in fellow eye
|
|
7.3 Results |
109 |
|
|
Unilateral |
Bilateral |
||
|
(n = 54) |
(n = 21) |
||
Associated |
8 |
|
(No subdifferen- |
|
disease; |
Anophthalmos |
tiation possible |
||
fellow eye |
■ |
Two clefting of lip, |
because both |
|
unremark- |
|
upper jaw, and palate |
eyes affected) |
|
able (Fig. 7.4) |
■ |
One oblique facial cleft |
|
|
|
■ |
One subcortical |
|
|
|
|
cerebral atrophy with |
|
|
|
|
secondary ventricle |
|
|
|
|
enlargement, |
|
|
|
|
hypoplasia of the |
|
|
|
|
corpus callosum |
|
|
|
■ |
One Goldenhar |
|
|
|
|
syndrome; clefting of lip, |
|
|
|
|
upper jaw, and palate; |
|
|
|
|
deafness (suspected |
|
|
|
|
aplasia of cranial nerve |
|
|
|
|
VIII); congenital |
|
|
|
|
clubfoot bilaterally (pes |
|
|
|
|
equino-varus); |
|
|
|
|
developmental |
|
|
|
|
anomalies of extremi- |
|
|
|
|
ties, chest, and vertebrae |
|
|
|
■ |
One unilateral renal |
|
|
|
|
agenesis |
|
|
|
■ |
One atrioseptal defect |
|
|
|
Microphthalmos |
|
|
|
|
■ |
One atrioseptal defect, |
|
|
|
|
unilateral preauricular |
|
|
|
|
tag |
|
|
Fig. 7.1 Girl with right-sided anophthalmos in isolation, before and after completion of treatment
110 |
7 Systemic and Ophthalmic Anomalies in Congenital Anophthalmic or Microphthalmic Patients |
Summary for the Clinician
■ There was no difference in the rate of developmental anomalies in unilateral and bilateral 7 anophthalmos. Typically, the pathology is characterized by Goldenhar syndrome, facial cleft-
ing, and cerebral anomalies.
7.3.7 Developmental Anomaly and Potential
Visual Capacity of the Fellow Eye
in Unilateral Disease
Fig. 7.2 Sclerocornea affecting only eye (visual acuity: light perception) and status following two cyclophotocoagulation procedures for secondary glaucoma; other side (not shown) with anophthalmos and uncomplicated expander treatment
|
Developmental |
Legally blind |
|
anomaly |
|
Microphthalmos (n = 16) |
4 (25%) |
2 (12.5%) |
Anophthalmos (n = 38) |
18 (47.4%) |
13 (34.2%) |
a |
b |
Fig. 7.3 Girl with clinical anophthalmos on right side; the fellow eye has upper lid coloboma and lipodermoid of the limbus; general Goldenhar syndrome; preauricular tags bilaterally; clefting of lip, upper jaw, and palate on left side; cleft tongue; auricular dysplasia; external auditory meatus absent. (a) Initial findings. (b) Current findings with prosthesis and orbital expander on right side; upper lid coloboma on left side reconstructed
Fig. 7.4 MRI of a patient with anophthalmos on left side (orbital expander implanted, prosthesis inserted), ophthalmologically healthy right eye without gaze fixation due to complex developmental cerebral anomaly with subcortical cerebral atrophy, and resultant ventricular enlargement and hypoplasia of the corpus callosum
